Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001231919-25-000435
Filing Date
2025-11-05
Accepted
2025-11-05 20:13:33
Documents
1
Period of Report
2025-11-05

Document Format Files

Seq Description Document Type Size
1 form3-11062025_011125.html 3  
1 form3-11062025_011125.xml 3 10003
  Complete submission text file 0001231919-25-000435.txt   13705
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42938 | Film No.: 251455688

Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42938 | Film No.: 251455689

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42938 | Film No.: 251455686

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42938 | Film No.: 251455685

Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA Capital Nexus Fund III, L.P. (Reporting) CIK: 0001883840 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42938 | Film No.: 251455687

Mailing Address 1841 PAGE MILL RD PALO ALTO CA 94304
Business Address 1841 PAGE MILL RD PALO ALTO CA 94304 (650) 223-7745
Evommune, Inc. (Issuer) CIK: 0002044725 (see all company filings)

EIN.: 850742575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)